BrainsWay Ltd. announced the formation of a strategic partnership with a prominent mental health clinical treatment provider with an increasingly expanding footprint in the Northeast region of the United States. As a result of this partnership and a series of successive orders, a total of 10 Deep Transcranial Magnetic Stimulation (Deep TMS) systems will be installed by this provider in 2023 alone, with the potential for additional systems thereafter.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
954.3 ILa | -1.91% | -0.59% | -16.95% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.95% | 83.26M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- BWAY Stock
- News BrainsWay Ltd.
- Brainsway Ltd. Forges Strategic Partnership with Treatment Provider in Northeast U.S